Full-Time

Clinical Trial Manager

Posted on 11/7/2024

Corcept Therapeutics

Corcept Therapeutics

201-500 employees

Develops cortisol modulators for medical conditions

Biotechnology
Healthcare

Compensation Overview

$152.1k - $178.9kAnnually

Senior

No H1B Sponsorship

San Carlos, CA, USA

Requires on-site attendance three days a week.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Google Cloud Platform

You match the following Corcept Therapeutics's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Relevant BS / BA degree or nursing degree
  • 6+ years’ experience as a CRA or field monitor in a biotech, pharmaceutical, or CRO company
  • Study-related management experience
  • Attention to detail and ability to prioritize tasks to meet critical deadlines
  • Excellent verbal and written communication
  • Able to collaborate effectively with the study team, cross-functional team members, and external partners
  • Knowledge of US and GCP/ICH regulations
  • Understanding of the clinical trials process, the application of SOPs, and medical terminology
  • Strong interpersonal, problem-solving, and organizational skills
  • Self-motivated and able to motivate others
  • Sound judgment and discretion
  • Ability to read and understand scientific literature
  • Strong organization and time management skills
  • Ability to develop and deliver compelling and concise presentations
  • Able to work effectively on project teams and independently
  • Strong proficiency in Microsoft Office and ability to utilize a wide range of computer applications and tools
Responsibilities
  • Responsible for the implementation and quality execution of assigned clinical protocols according to Corcept SOPs, ICH/GCP, and corporate and department program goals
  • May serve as a Study Lead to the multifunctional team to ensure clinical study/studies activities, including study start-up, enrollment, maintenance, and closeout, are executed per timelines and budget
  • Oversees aspects of study management and vendors to ensure high quality of data
  • Providing Clinical Research Associates with project-specific training, guidance, and oversight, assigning deliverables and having regular meetings with them
  • Develops clinical trial protocol synopsis, protocols, amendments as directed by the Clinical Development team and while working with Medical Writing
  • Develops critical study documents such as informed consent form templates, site management, and monitoring tools
  • Evaluates study designs from an operations perspective, and considers site implementation tactics to suggest feasible solutions and contribute to overall program design and execution
  • Develops study timelines and budgets per the corporate and departmental goals and continuously strives to ensure timelines and deliverables are met within budget
  • Responsible for tracking and managing study execution to resources and goals
  • Facilitating the CRO/Vendor selection process for outsourced activities, including developing an RFP, managing the bidding process, analysis of proposals, budgets, and leading and documenting vendor selection decisions. Includes review of Scope of Work, budgets, and negotiating contracts through execution
  • Escalates concerns regarding timelines, milestones, resourcing, and any potential study execution issue to appropriate internal stakeholders
  • Creates a process for developing distribution, reviews, and tracking essential trial documents and/or oversees CRO or CRA responsibility for essential documents
  • Collaborates with team CRAs to ensure essential trial documents are provided to Regulatory for submission to the FDA and other regulatory agencies for IND Updates and Amendments
  • Develops and ensures compliance with clinical monitoring plan; conducts or oversees co-monitor as needed for staff training and quality assurance (QA) purposes
  • May conduct and/or attend PSVs, SIVs, IMVs, and COVs
  • Partners in the development of the case report form (CRF) design process including content, form layout, and edit check review
  • Liaison with chemistry, manufacturing, and controls (CMC) team to forecast and monitor overall drug supply and expiration to ensure adequate availability throughout the trial
  • Ensures CRA(s) maintain a complete and updated regulatory file for each assigned site
  • Manages oversight of Investigational Product (IP) accountability and ensures adequate site supply
  • Manages safety reporting to sites and regulatory agencies
  • Procures and manages contracts with CROs, study vendors, and investigative sites
  • Manages and/or provides oversight of CROs, independent field monitors, and other clinical vendors
  • Ensures monitoring trip reports are reviewed and track resolution of all action items on time, per the Monitoring Plan or Corcept SOPs
  • Co-monitors at investigative sites to evaluate study site and field monitor performance
  • Manages, either directly or through supervised delegation, other study-wide activities such as external vendors, sample handling, drug re-supply, investigator payments, overall data quality, and overall central records quality
  • Serves as in-house contact for protocol-related process questions and tracks questions/processes for best practices and consistency
  • May help audits clinical data reports for accuracy, safety, and/or efficacy trends; as necessary prepare related presentations
  • Exercises sound judgment to resolve or, as appropriate seek expert input on protocol and drug questions, safety, regulatory, and legal questions. Ensures resolution is tracked and consistently messaged to all team members and clinical sites
  • Contribute to the SOP review process and other Clinical Operations Initiatives, as necessary
  • Demonstrates excellent knowledge of ICH guidelines, FDA regulations, and company SOPs related to clinical studies and coach junior staff on the same
  • Ensures Trial Master File is maintained throughout the study
  • Practices professionalism and integrity in all actions and relationships with Corcept management, supervisors, team members, direct reports, and vendors. Exhibits and models leadership behavior through communication and appropriate temperament. Ability to have difficult/crucial conversations with tact. Demonstrates ability to foster teamwork, cooperation, self-mastery, and flexibility to get the work done. Maintains composure under difficult circumstances
  • Travel may be up to 30% occasionally
  • This position may supervise the following positions: Clinical Operations Consultants and Clinical Research Associates
  • This headquarters-based role requires on-site attendance three days a week

Corcept Therapeutics focuses on developing treatments that regulate cortisol levels in the body, which is important for managing stress, metabolism, and immune functions. Their main product, Korlym, is the first FDA-approved treatment for Cushing's syndrome, a condition caused by excessive cortisol. The company has discovered over 1,000 cortisol modulators and aims to expand its offerings with new treatments in development. Unlike many competitors, Corcept emphasizes both research and patient education, providing resources to improve understanding and care for cortisol-related disorders. The goal of Corcept is to enhance patient outcomes by delivering effective therapies and supporting education in the medical community.

Company Stage

IPO

Total Funding

$39.7M

Headquarters

Menlo Park, California

Founded

1998

Growth & Insights
Headcount

6 month growth

3%

1 year growth

2%

2 year growth

-3%
Simplify Jobs

Simplify's Take

What believers are saying

  • Increased interest in cortisol therapies for mental health boosts Corcept's R&D prospects.
  • Advancements in drug delivery systems could enhance Corcept's product efficacy.
  • The FDA's fast-track designation supports Corcept's innovative cortisol-related treatments.

What critics are saying

  • Teva's antitrust lawsuit could lead to legal expenses and market share loss.
  • Heavy reliance on Korlym makes Corcept vulnerable to market fluctuations.
  • Recent investments may pressure Corcept for short-term financial performance, impacting R&D.

What makes Corcept Therapeutics unique

  • Corcept specializes in cortisol modulation, a niche with few direct competitors.
  • Korlym is the first FDA-approved treatment for Cushing's syndrome, a significant market advantage.
  • Corcept's extensive R&D has led to the discovery of over 1,000 selective cortisol modulators.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Flexible Work Hours

INACTIVE